NCT05917314

A Study to Evaluate the Effect of SlimBiotics Probiotic Formula on Weight Management and Metabolic Health Outcomes

A Randomized, Double-blind, Placebo-controlled Study to Evaluate the Effect of SlimBiotics Probiotic Formula on Weight Management and Metabolic Health Outcomes

• Status: Completed
• Phase: N/A
• Study type: Interventional
• Enrollment: 120 (actual)
• Sponsor: Slimbiotics · Unknown
• Sex: All
• Age: 18 Years
• Healthy volunteers: Accepted

Summary

This study is to evaluate the efficacy of a probiotic supplement on weight management and metabolic health. This study will be conducted as a hybrid trial consisting of both in-person visits and virtual assessments. Two groups will be included: the intervention (SlimBiotics Probiotic) and placebo. The SlimBiotics probiotic formula is the first plant-based probiotic targeting weight management and metabolic health. Other competing probiotics are isolated from humans (feces) but the strains in SlimBiotics were isolated from a fermented plant (millet porridge cereal). This product contains 3 probiotic strains: Limosilactobacillus fermentum K7-Lb1 Limosilactobacillus fermentum K8-Lb1 Limosilactobacillus fermentum K11-Lb3

Conditions

• Metabolic Health
• Weight Loss
• Stress
• Well-Being, Psychological
• Sleep
• Healthy Eating

Interventions

Type	Name	Description
OTHER	Slimbiotic Probiotic	SlimBiotics Probiotic formula contains three probiotic strains of L. fermentum: * Limosilactobacillus fermentum K7-Lb1 * Limosilactobacillus fermentum K8-Lb1 * Limosilactobacillus fermentum K11-Lb3 The product also contains Microcrystalline cellulose.
OTHER	Placebo	The placebo capsule contains microcrystalline cellulose.

Timeline

• Start date: 2023-07-01
• Primary completion: 2023-11-24
• Completion: 2023-11-30
• First posted: 2023-06-23
• Last updated: 2024-08-23

Locations

1 site across 1 country: United States